PHILIPS KON JUN9 Inactive Instrument
PHILIPS KON JUN9 Share Price Euronext Amsterdam
Equities
Advanced Medical Equipment & Technology
| Sales 2024 * | 18.8B 20.1B 0 1,677B | Sales 2025 * | 19.73B 21.1B 0 1,760B | Capitalization | 17.9B 19.14B 0 1,596B |
|---|---|---|---|---|---|
| Net income 2024 * | 702M 751M - 62.61B | Net income 2025 * | 1.12B 1.19B - 99.53B | EV / Sales 2024 * | 1.23 x |
| Net Debt 2024 * | 5.27B 5.63B 0 470B | Net Debt 2025 * | 4.3B 4.6B 0 383B | EV / Sales 2025 * | 1.12 x |
| P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
17.4
x | Employees | - |
| Yield 2024 * |
4.48% | Yield 2025 * |
4.66% | Free-Float | 99.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on PHILIPS KON JUN9
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 01/10/01 |
| Director of Finance/CFO | 62 | 01/87/01 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 22/21/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 01/15/01 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 01/22/01 |
| Director/Board Member | 68 | 01/21/01 |
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
29/04/2024
- Q1 2024 Earnings Release
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
